FDA Approves New Treatment for Macular Degeneration
October 24, 2026
The most recent development for age-related macular degeneration (ARMD) is a treatment for a specific form of dry ARMD. This form, called Geographic Atrophy (GA), affects over 5 million people across the world, and is responsible for 20% of legal blindness in the United States. G...
View More